Cure My Disease

Don't miss your cure!

 Log in / Sign up

Study seeks to improve cancer screening for transgender individuals before hysterectomy

NCT ID NCT07075731

Recruiting now Knowledge-focused Sponsor: University of Minnesota Source: ClinicalTrials.gov ↗

First seen Jul 16, 2026 · Last updated Jul 17, 2026 · Updated 1 time

Summary

This study examines how often transgender and gender-diverse individuals receive cervical and endometrial cancer screening before undergoing gender-affirming hysterectomy. Researchers will review medical records and explore whether offering HPV self-testing could increase screening rates. The goal is to gather data that could lead to better, more inclusive screening guidelines for this population.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this study could help create evidence-based cancer screening guidelines tailored to transgender and gender-diverse individuals.
What could go wrong
This is a small, observational study at a single center, so findings may not apply broadly. It does not test a new treatment or intervention.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER SCREENING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CANCER SCREENING GENDER DIVERSE POPULATIONS TRANSGENDER

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Minnesota

    RECRUITING

    Minneota, Minnesota, 55455, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.